Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT05156905 · TERMINATED
Trial details
- NCT number
- NCT05156905
- Sponsor
- University of California, San Diego
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-16
- Primary completion
- 2024-10-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.